Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: Economic News/Analysis

Europe Drug Discovery Market (2020 to 2030) - Trend Forecast and Growth Opportunities - ResearchAndMarkets.com


The "Europe Drug Discovery Market 2020-2030 by Drug Type, Service, Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

Europe drug discovery market was valued at $14.8 billion in 2020 and will grow by 8.3% annually over 2020-2030 owing the rising demand for specialty medicines, the surge in lifestyle-oriented diseases and the advancements in technology, the growing elderly population and the rising healthcare expenses, rising expenditure on R&D, and expiration of patents.

Key Players:

The report is based on a comprehensive research of the entire Europe drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain.

The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).

In-depth qualitative analyses include identification and investigation of the following aspects:

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe drug discovery market in every aspect of the classification from perspectives of Drug Type, Service, Process, Technology, Therapeutic Area, End User, and Country.

Based on Drug Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.

Based on Service, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.

Based on Process, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.

Based on Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.

Based on Therapeutic Area, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.

Based on End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.

Geographically, the following national/local markets are fully investigated:

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Drug Type, Service, and Therapeutic Area over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

For more information about this report visit https://www.researchandmarkets.com/r/3sbur7


These press releases may also interest you

at 12:05
Seeking Comfort That Performs® on the court, Los Angeles Clippers shooting guard Norman Powell is now exclusively playing in Skechers Basketball footwear after signing with the performance brand. Powell is set to compete in the 3-point contest during...

at 12:00
The "eClinical Solutions - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for eClinical Solutions was valued at US$11.4 Billion in 2024 and is projected to reach US$22.7 Billion by 2030,...

at 12:00
Triller, the leading social media and video-sharing platform, is excited to announce the launch of its highly anticipated redesign, showcasing a completely refreshed look and feel. The new interface provides users with a modern, intuitive, and...

at 11:35
The Los Angeles County Economic Development Corporation (LAEDC) is proud to announce a generous $300,000 contribution from CTBC Bank to support its ongoing efforts to aid small business recovery in the aftermath of the recent Los Angeles wildfire...

at 10:30
The global remote patient monitoring market, valued at US$24.39 billion in 2023, is forecasted to grow at a robust CAGR of 12.7%, reaching US$27.72 billion in 2024 and an impressive US$56.94 billion by 2030. The key drivers behind this growth include...

at 10:05
Pfizer Inc. today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide), an androgen receptor pathway inhibitor (ARPI),...



News published on and distributed by: